- Home
- EDUC vs ADXN Comparison
EDUC vs ADXN Comparison
Compare EDUC & ADXN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | EDUC | ADXN |
|---|---|---|
| Founded | 1965 | 2002 |
| Country | United States | Switzerland |
| Employees | N/A | N/A |
| Industry | Consumer Specialties | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 11.8M | 10.3M |
| IPO Year | 1995 | 2019 |
Fundamental Metrics
Financial Performance| Metric | EDUC | ADXN |
|---|---|---|
| Price | $1.32 | $7.12 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 23.1K | 3.1K |
| Earning Date | 04-14-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ 0.63 | N/A |
| Revenue | ★ $34,191,000.00 | N/A |
| Revenue This Year | N/A | $86.57 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $2.13 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.92 | $6.51 |
| 52 Week High | $1.84 | $12.05 |
Technical Indicators
Market Signals| Indicator | EDUC | ADXN |
|---|---|---|
| Relative Strength Index (RSI) | 40.26 | 42.76 |
| Support Level | $1.32 | $6.82 |
| Resistance Level | $1.36 | $8.74 |
| Average True Range (ATR) | 0.06 | 0.29 |
| MACD | -0.01 | -0.04 |
| Stochastic Oscillator | 25.00 | 12.61 |
Price Performance
Historical ComparisonAbout EDUC Educational Development Corporation
Educational Development Corp is the United States trade publisher of the line of educational children's books produced in the United Kingdom. Its business activity functions with two reportable segments: PaperPie and Publishing. The Publishing Division segment markets its products to retail accounts, which include books, school supplies, toy and gift stores and museums, through commissioned sales representatives, trade and specialty wholesalers and an internal telesales group.
About ADXN Addex Therapeutics Ltd
Addex Therapeutics Ltd is a clinical-stage biopharmaceutical company. The company is focused on the development and commercialization of an emerging class of novel orally available small-molecule drugs known as allosteric modulators. The company's geographical area of operations includes Switzerland and Europe. The Company operates in one segment, which is the discovery, development, and commercialization of small-molecule pharmaceutical products.